Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

China flag China · Delayed Price · Currency is CNY
191.79
-7.21 (-3.62%)
Jul 21, 2025, 3:00 PM CST
649.77%
Market Cap17.68B
Revenue (ttm)488.02M
Net Income (ttm)-220.07M
Shares Out88.83M
EPS (ttm)-2.33
PE Ration/a
Forward PEn/a
Dividend0.20 (0.10%)
Ex-Dividend Daten/a
Volume2,502,687
Average Volume3,213,784
Open195.00
Previous Close199.00
Day's Range188.05 - 197.67
52-Week Range22.94 - 207.00
Beta1.53
RSI61.46
Earnings DateAug 30, 2025

About Beijing Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, mi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 903
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688068
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.